AMETEK Posts Record Q2, Lifts Full-Year Outlook on 28% Orders Surge
AME sits 37% above its 52-week low of $179.235 on light trading volume (0.3× avg).
Summary
Record Q2 2026 results featured sales of $2.04B (+15% YoY) and adjusted EPS of $2.09 (+17% YoY). Orders surged 28%, and the company raised its full-year adjusted EPS guidance to $8.20–$8.30.
Key Events · Earnings and Guidance · AME
-
Record Q2 Sales and Earnings
Sales reached $2.04 billion, up 15% year-over-year, while adjusted EPS rose 17% to $2.09, driven by strong organic growth and contributions from recent acquisitions.
-
Orders Surge 28%
Orders grew 28% in the quarter, with notable strength in semiconductor, commercial aerospace, medtech, defense, and automation markets, indicating robust demand across both segments.
-
Full-Year Guidance Raised
Management increased 2026 adjusted EPS guidance to $8.20–$8.30, up from $7.94–$8.14, reflecting confidence in continued strong performance. Q3 adjusted EPS is expected to be $2.08–$2.10.
-
Margin Expansion Across Segments
Adjusted operating margins expanded 60 basis points to 26.6%, with core margin expansion of 110 basis points. EIG core margins rose 40 bps to 30.1%, and EMG core margins jumped 290 bps to 26.2%.
Analysis · AME · Industrial Applications And Services
A standout quarter saw sales climb 15% to $2.04 billion and adjusted EPS reach $2.09, a 17% improvement over the prior-year period. Orders jumped 28%, signaling robust demand across semiconductor, aerospace, medtech, and automation markets. Reflecting confidence in sustained momentum, management raised full-year adjusted EPS guidance to $8.20–$8.30, a 3% increase at the midpoint. With the stock trading near its 52-week high, these results reinforce the premium valuation. The combination of broad-based organic growth, margin expansion, and raised guidance makes this a thesis-affirming report for a $56 billion industrial compounder.
At the time of this filing, AME was trading at $246.04 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $56.4B. The 52-week trading range was $179.24 to $257.40. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.